A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Columbia University, New York

West Virginia University Eye Institute, Morgantown

Wake Forest Baptist Health Eye Center, Winston-Salem

Hospital La Princesa, Madrid

Hospital Universitario Ramon y Cajal, Madrid

Bascom Palmer Eye Institute, Miami

Center for Excellence in Eye Care, Miami

Sarasota Retina Institute, Sarasota

Kellogg Eye Center, Ann Arbor

Kahana Oculoplastic & Orbital Surgery, Livonia

Wolfe Eye Clinic, West Des Moines

Chicago Oculofacial Plastic Surgery, Chicago

Washington University in St. Louis/Barnes Jewish Hospital, Creve Coeur

Neuro-Eye Clinical Trials, Inc., Bellaire

Eyelid Center of Utah, Salt Lake City

UCLA, Los Angeles

Thrive Health Research, Beverly Hills

UC San Diego Health, La Jolla

Byers Eye Institute - Stanford University, Palo Alto

Oregon Health and Science University, Portland

Mass Eye and Ear, Boston

Vancouver Coastal Health Eye Care Center, Vancouver

Toronto Retina Institute, North York

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Endocrinology Pawilione Zonda, Milan

AOU Pisana, Pisa

University of Pisa, Pisa

Hospital Universitari de Bellvitge, Barcelona

Frimley Health Foundation Trust, Camberley

Cardiff University, Cardiff

Moorfields Eye Hospital NIHR Clinical Research Facility, London